Extracted text (via pymupdf)
42349 characters
Last Updated: January 15, 2015
MASTER INTERGOVERNMENTAL AGREEMENT
This Master Intergovernmental Agreement (“Agreement”) is entered into this ___ day of July, 2020 (the
“Effective Date”) by and between Maricopa County, by and through its Department of Public Health
having its principal place of business at 4041 N Central Avenue, Suite 1400 (“Maricopa”) and The Arizona
Board of Regents for and on behalf of Arizona State University (“ASU”).
RECITALS
A.
A.R.S. §§ 11-951, et. seq. provide that public agencies may enter into governmental
agreements for the provisions of services or joint cooperative action.
B.
ASU desires to provide COVID-19 response aid to Maricopa County Department of Public
Health (“MCDPH”). Support will include, but is not limited to, serving on behalf of MCDPH as COVID-19
public health investigators, supporting with COVID-19 cluster responses and other projects related to
COVID-19 as they arise.
C.
ASU desires to provide students with experiential learning opportunities, enhance
MCDPH’s COVID response and contribute to the health and wellness of Maricopa County citizens. ASU
students will function under the Maricopa County Office of Epidemiology and Data Services (OE) but will
be coordinated by the Public Health Incident Command Structure (ICS) in coordination with the
Maricopa County Office of Preparedness and Response (OPR).
D.
Maricopa desires to engage ASU to perform certain services as Maricopa may require
from time to time (the “Services”) and described in each scope of work (each, a “SOW”) agreed to by the
parties in the form set forth on Exhibit A hereto, which is incorporated herein by this reference. The
terms and conditions of each Exhibit issued under this Agreement shall be agreed upon by ASU and
Maricopa.
E.
The performance of the Services is consistent, compatible, and beneficial to the role and
mission of ASU.
AGREEMENT
1.
Scope of Work. ASU’s Biodesign Institute and other ASU departments will use reasonable efforts
to provide the Services. The parties agree that ASU will have discretion to involve its students in
the conduct and performance of the Services to the extent permitted by law. ASU’s performance
of the Services and its obligations under this Agreement are subject to and governed by the
regulations and policies of the Arizona Board of Regents. ASU shall provide written test results to
Maricopa when available and any positive test results will be reported to the authorities as
required by applicable law. Maricopa shall be responsible for reporting all test results to
individuals tested; ASU shall have no such obligation.
2.
Scheduling Services. The scheduling of the Services will be arranged to avoid conflict with ASU’s
educational and research programs. ASU will control the scheduling of such Services but will try to
2
meet the timelines established by Maricopa.
3.
Term and Termination.
3.1
The term of this Agreement will be one year commencing on the Effective Date and will
terminate as provided herein. The parties may modify or extend this Agreement at any
time by mutual written consent, including in any SOW.
3.2
Either party may terminate this Agreement at any time by giving the other party not less
than fifteen (15) days prior written notice. If this Agreement is terminated by Maricopa,
Maricopa will remain responsible for payment to ASU for all Services performed through
the date of termination and for reimbursement to ASU of all non-cancelable
commitments incurred in the performance of the Services. Upon termination, property
purchased in furtherance of this Agreement will remain the property of the purchasing
party, unless expressly specified otherwise.
4.
Compensation and Invoicing.
4.1
Budget. Maricopa agrees to pay ASU for the Services performed under this
Agreement in accordance with the budget set forth in the Exhibits. Total not-to-
exceed expense for the one-year budget period, including 10% indirect to ASU, is not
to exceed $1,609,040.
4.2
Maricopa will remit the amount of the contract price due for Services rendered under
this Agreement upon execution of the SOWs and at agreed upon Payment Schedule in
the SOWs. Invoices are due and payable within 30 days and are payable in full regardless
of whether Maricopa is reimbursed for the testing, whether by patients, patient
representatives, or third-party payors, including any government health care program.
Maricopa will send checks or paper remittance advices to address contained in SOW.
4.3
ASU reserves the right to subject invoices not paid within thirty (30) days of the invoice
date to a 1.5% per month late fee on the unpaid balance for any amounts not in dispute.
ASU reserves the right to discontinue the Services if Maricopa fails to make payments
when due. In the event of non-payment, ASU may terminate all further work on the
Services and seek full payment from Maricopa for all work performed and all expenses
incurred including allocable costs, pursuant to the termination clause of this Agreement
including the collection of payment. Should it become necessary for ASU to commence
collection proceedings or retain an attorney to enforce any of the terms of this
Agreement, Maricopa will pay all attorneys’ fees and the costs of collection incurred by
ASU.
4.4
Funding for this IGA is provided by the ‘Coronavirus Aid, Relief, and Economic Security
(CARES) Act’ which is to end December 30, 2020. Should the CARES Act funds cease on
December 30, 2020, and alternative funds are not available, County will suspend or
cancel this agreement.
3
5.
No Warranty, Limitation of Liability.
5.1
Maricopa agrees that ASU does not make any representation or warranty for the
accuracy of the Services. Maricopa further agrees that all Services are provided on an
“AS-IS” and as available basis. ASU assumes no responsibility for the accuracy or lack of
accuracy of any testing provided under the Services. Maricopa agrees to assume any
risk for the inaccuracy of such testing.
5.2
TO THE FULLEST EXTENT PERMITTED BY LAW, ASU and ASU’S BIODESIGN INSTITUTE
DISCLAIM ALL WARRANTIES, EITHER EXPRESS OR IMPLIED, STATUTORY OR
OTHERWISE, RELATED TO THE SERVICES INCLUDING, WITHOUT LIMITATION, ANY
WARRANTY OF SATISFACTORY QUALITY, FITNESS FOR A PARTICULAR PURPOSE OR
NON-INFRINGEMENT OF ANY THIRD-PARTY INTELLECTUAL PROPERTY OR
PROPRIETARY RIGHTS.
5.3
Limitation of Liability. Maricopa agrees, to the fullest extent permitted by law: 1) ASU
shall not be liable for any consequential, incidental, indirect, special, reliance, punitive,
or exemplary damages or losses, whether in contract, tort, or otherwise, that arise in
any way out of this Agreement or the Services; and 2) IN NO EVENT WILL THE
AGGREGATE LIABILITY OF ASU IN ANY MATTER ARISING FROM, RELATING TO OR
CONNECTED WITH THIS AGREEMENT OR THE SERVICES EXCEED $100.
6.
Federal and State Patient Privacy Laws. ASU Biodesign Institute is not a Covered Entity nor a
Business Associate under the Health Insurance Portability and Accountability Act (“HIPAA”).
7.
Disclaimers. Maricopa agrees that ASU may obtain a signed disclaimer in the form substantially
similar to that attached as Exhibit B, from any individual that ASU obtains a sample from.
8.
Authorization to Take Sample. Maricopa represents and warrants to ASU that it has obtained all
necessary authorizations and consents to take the samples and that the individuals to be tested
have consented to be tested for COVID-19.
9.
Indemnification. Maricopa will indemnify, defend, save and hold harmless the State of Arizona,
its departments, agencies, boards, commissions, universities, and its and their officials, agents,
and employees (collectively, “Indemnitee”) for, from, and against any and all claims, actions,
liabilities, damages, losses, or expenses (including court costs, attorneys’ fees, and costs of claim
processing, investigation, and litigation) arising out of or in any way related to this Agreement or
the Services. Maricopa will be responsible for primary loss investigation, defense, and judgment
costs where this indemnification is applicable.
10.
No University Endorsements. In no event will Maricopa (or its successors, employees, agents and
contractors) state or imply in any publication, advertisement or other medium that ASU has
approved, endorsed or tested any product or service. In no event will ASU’s performance of any
Services hereunder be considered a test of the effectiveness or the basis for any endorsement of a
product or service.
11.
Use of Names or Logos. Neither party will use any names, service marks, trademarks, trade
names, logos or other identifying names, domain names or identifying marks of the other party
4
(“Marks”), or the name of any representative or employee of the other party in any sales
promotion work or advertising, or any form of publicity, without the prior written permission of
the party that owns the Marks in each instance. Use of any party’s Marks must comply with the
owning party’s requirements, including using the “®” indication of a registered trademark where
applicable.
12.
Similar Research. Nothing in this Agreement will be construed to limit the freedom of ASU or of
its researchers from engaging in similar services made under other grants, contracts or
agreements with parties other than Maricopa.
13.
Export Controls. Maricopa will notify ASU in writing if any technological information or data
provided to ASU under this Agreement is subject to export controls under U.S. law or if
technological information or data that Maricopa is requesting ASU to produce during the course
of work under this Agreement is expected to be subject to such controls. Maricopa will notify ASU
of the applicable export controls (for example, Commerce Control List designations, reasons for
control, countries for which an export license is required). ASU will have the right to decline
export-controlled information or tasks requiring production of such information.
14.
Independent Contractor. Each party is an independent contractor and is independent of the
other party. Under no circumstances will any employees of one party be deemed the employees
of the other party for any purpose. This Agreement does not create a partnership, joint venture
or agency relationship between the parties of any kind or nature. This Agreement does not create
any fiduciary or other obligation between the parties, except for those obligations expressly and
specifically set forth herein. Neither party will have any right, power, or authority under this
Agreement to act as a legal representative of the other party, and neither party will have any
power to obligate or bind the other or to make any representations, express or implied, on behalf
of or in the name of the other in any manner or for any purpose whatsoever contrary to the
provisions of this Agreement. Each party acknowledges that the relationship of the parties
hereunder is non-exclusive.
15.
No Referral Obligation. The parties each represent and warrant on behalf of itself, that the
aggregate benefit given or received under this Agreement has been determined in
advance through a process of arms-length negotiations that was intended to achieve an
exchange of goods and/or services consistent with fair market value under the
circumstances, and that any benefit given or received under this Agreement is not
intended to induce, does not require, and is not contingent upon, the admission,
recommendation or referral of any patient, directly or indirectly, and further, is not
determined in any manner that takes into account the value of business generated
between the parties. Nothing herein restricts or is intended to restrict the parties from
making referrals for goods or services to any individual or entity. The parties represent
and warrant that this Agreement does not involve the counseling or promotion of a
business arrangement that violates federal or state law.
16.
Notices. All notices, requests, demands and other communications hereunder will be deemed to
have been duly given if the same shall be in writing and be delivered (a) personally, (b) by
5
registered or certified mail, postage prepaid, (c) by facsimile transmission, with a copy by regular
mail or (d) by overnight delivery service and addressed to the recipient’s business address.
17.
Force Majeure. Neither Party is responsible for a failure to perform any obligation under this
Agreement if such failure to perform is directly caused by a Force Majeure Event. A “Force
Majeure Event” shall mean an event or circumstance that is beyond the reasonable control and
without the fault or negligence of the Party impacted (other than for obligations to make
payments when due under this Agreement), and that could not have been prevented by the
reasonable diligence of the party. Without in any way limiting the foregoing, a Force Majeure
Event may include, but are not restricted to (a) acts of God or of a public enemy, (b) acts of the
Government in either its sovereign or contractual capacity, (c) fires, (d) floods, (e) epidemics or
pandemics, (f) quarantine restrictions, (g) strikes, (h) freight embargoes; (i) failure or disruption of
utilities or critical electronic systems, (j) mass health issues or disease, and (k) unusually severe
weather. In the event that a Party is impacted by a Force Majeure Event, that Party will give
prompt notice to the other Party and take commercially practical actions to mitigate the impacts
of the Force Majeure Event.
18.
Applicable Law. Any dispute regarding or arising under this Agreement, or the interpretation of
this Agreement, will be subject to and resolved in accordance with the laws of the State of
Arizona, without regard to its conflicts of laws principles.
19.
Dispute Resolution. In the event of any dispute, claim, question, or disagreement arising from or
relating to this Agreement or the breach thereof, the parties hereto will use their reasonable
efforts to settle the dispute, claim, question, or disagreement. To this effect, they will consult and
negotiate with each other in good faith and, recognizing their mutual interests, attempt to reach a
just and equitable solution satisfactory to both parties. In the event of litigation, as required by
Arizona Revised Statutes (“A.R.S.”) §12-1518, the parties agree to make use of arbitration in all
contracts that are subject to mandatory arbitration pursuant to rules adopted under A.R.S. §12-
133.
20.
Medicare Access to Books and Records. For the purposes of implementing Section 1861(v)(1)(I)
of the Social Security Act, as amended, and any regulations promulgated pursuant thereto, ASU
agrees that until the expiration of four (4) years after the furnishing of the Services, it will make
available, upon written request to the Secretary of the US Department of Health and Human
Services or upon request to the Comptroller General, or any of their duly authorized
representatives, the contracts, and books, documents and records of ASU necessary to certify the
nature and extent of such costs
21.
Assignment. Neither party will assign or transfer any interest in this Agreement without the prior
written approval of the other party. Any attempted assignment in violation of this provision will
be null and void. Subject to the foregoing, this Agreement will be binding upon the permitted
successors and permitted assigns or other permitted transferees of the parties.
22.
Recitals and Exhibits. All recitals herein, and all exhibits attached hereto and referred to herein,
are integral and material parts of this Agreement.
23.
Severability. If any provision of this Agreement shall for any reason be found invalid, illegal,
unenforceable, or in conflict with any valid controlling law: (a) such provision will be separated
6
from this Agreement; (b) such invalidity, illegality, unenforceability, or conflict will not affect any
other provision hereof; and (c) this Agreement will be interpreted and construed as if such
provision, to the extent the same shall have been held invalid, illegal, unenforceable, or in conflict,
had never been contained herein.
24.
Waiver. The waiver of a breach hereunder may be effected only by a writing signed by the
waiving party and will not constitute, or be held to be, a waiver of any other or subsequent breach
or to affect in any way the effectiveness or enforceability of the provision in question.
25.
Modification. Any modification or amendment of this Agreement will be effective only if made in
writing and signed by both parties.
26.
No Third-Party Beneficiaries. Nothing in this Agreement, express or implied, is intended or will be
construed to confer upon any person or entity, other than the parties and their respective
successors and assigns permitted by this Agreement, any right, remedy or claim under or by
reason of this Agreement.
27.
Use of Data. The Parties will exercise due professional care in performance of the Services and in
accordance with Exhibit C.
28.
Merger and Integration. This Agreement contains the entire understanding between the parties
concerning the subject matter of this Agreement and supersedes any and all prior understandings,
agreements, representations, and warranties, express or implied, written or oral, between the
parties concerning the subject matter of this Agreement.
29.
Nondiscrimination. The parties agree to comply with all applicable state and federal laws, rules,
regulations and executive orders governing equal employment opportunity, immigration and
nondiscrimination, including the Americans with Disabilities Act.
30.
Conflict of Interest. In accordance with A.R.S. § 38-511, ASU may cancel this Agreement within
three years after the execution of this Agreement, without penalty or further obligation, if any
person significantly involved in initiating, negotiating, securing, drafting or creating this
Agreement on behalf of ASU, at any time while this Agreement or any extension thereof is in
effect, is an employee or agent of any other party to this Agreement in any capacity or a
consultant to any other party with respect to the subject matter of this Agreement.
31.
Failure of Legislature to Appropriate. In accordance with A.R.S. § 35-154, if ASU’s performance
under this Agreement depends on the appropriation of funds by the Arizona Legislature, and if the
Legislature fails to appropriate the funds necessary for performance, then ASU may provide
written notice of this to Maricopa and cancel this Agreement without further obligation of ASU.
Appropriation is a legislative act and is beyond the control of ASU.
32.
Counterparts. This Agreement may be executed in one or more counterparts, each of which will
be deemed an original, but all of which taken together will constitute one and the same
instrument, and photocopy, facsimile, electronic and other copies will have the same effect for all
purposes as an ink-signed original.
[SIGNATURES ON NEXT PAGE.]
7
IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be executed by their duly
authorized representatives on the respective dates entered below.
THE ARIZONA BOARD OF REGENTS
MARICOPA COUNTY
FOR AND ON BEHALF OF
ARIZONA STATE UNIVERSITY
By:
By:
Name:
Name: Clint Hickman
Title:
Title:
Chairman, Board of Supervisors
Date:
Date:
INTERGOVERNMENTAL AGREEMENT DETERMINATION
In accordance with A.R.S. § 11-952, this Agreement has been reviewed by the undersigned who have
determined that this Agreement is in appropriate form and is within the powers and authority of the
respective parties.
Maricopa County
The Arizona Board of Regents for and on Behalf of
Arizona State University
By: _________________________
By: _____________________________
Attorney for County
Counsel for ASU
Date: ____________________
Date: ____________________________
ATTEST: _______________________________
Office of the Clerk of the Board Date
8
EXHIBIT A
Form of Scope of Work
This Scope of Work, dated July 1, 2020, is issued pursuant to, made part of, and governed by the Master
Services Agreement, dated July _, 2020 (“Master Agreement”), by and between Maricopa County
(“Partner”) having its principal place of business at 4041 N Central Avenue, Suite 1400, Phoenix, AZ
85012, and The Arizona Board of Regents for and on behalf of Arizona State University and its [Name of
Recharge Center / Service Center] (“ASU”).
1. Contact Details.
Technical Point of Contact for ASU:
Point of Contact for Partner:
Attention: [Contact Name]
Jeanene Fowler, Program Operations Administrator
Arizona State University
Maricopa County Department of Public Health
P.O. Box [______]
4041 N Central Avenue, Suite 1400
Tempe, Arizona 85287-[____]
Phoenix, AZ 85012
Fax: [_____________]
FAX: 602-506-6885
2. Scope of Work.
Description of Services:
Deliverable(s), if any:
3. Rate Schedule.
ASU Payment Address (if different than above address)
Attention: [_______________]
[Address]
Arizona State University
P.O. Box [______]
Tempe, Arizona 85287-[____]
Fax: [______________]
9
Exhibit B
Patient Disclaimer
By signing below, you understand and agree to the following:
1.
The Arizona Board of Regents for and on behalf of Arizona State University (“ASU”) and The
Biodesign Institute make no representation and assume no responsibility for the accuracy of
the testing – all testing results are provided on an “AS-IS” and as available basis.
2.
ASU and The Biodesign Institute TO THE FULLEST EXTENT PERMITTED BY LAW, DISCLAIM
ALL WARRANTIES, EITHER EXPRESS OR IMPLIED, STATUTORY OR OTHERWISE, RELATED TO
THE COVID-19 TESTING INCLUDING WITHOUT LIMITATION ANY WARRANTY OF
SATISFACTORY QUALITY, FITNESS FOR A PARTICULAR PURPOSE OR NON-INFRINGEMENT
OF ANY THIRD PARTY INTELLECTUAL PROPERTY OR PROPRIETARY RIGHTS.
3.
To the fullest extent permitted by applicable law, ASU and The Biodesign Institute do not
warrant the accuracy or completeness of the testing provided by the Biodesign Institute.
4.
Limitation of Liability. You hereby agree that to the fullest extent permitted by law:
a. ASU and The Biodesign Institute shall not be liable to you, or any of your heirs or
assigns, for any consequential, incidental, indirect, special, reliance, punitive, or
exemplary damages or losses, whether in contract, tort, or otherwise.
b. IN NO EVENT WILL THE AGGREGATE LIABILITY OF ASU OR THE BIODESIGN INSTITUTE IN
ANY MATTER ARISING FROM, RELATING TO OR CONNECTED WITH THIS MATTER EXCEED
$100.
Name: ________________________________________
Signature: _____________________________________
Date: ______________
10
Exhibit C – Data
1.
USE OF DATA
A.
Carefully restrict use and access of information to those designated by Maricopa.
1.
No data, in line list or aggregate form, may be released by ASU.
2.
Analysis authorized under this IGA is limited to the minimum necessary to ensure
completion of contract requirements as outlined in Section 3. Any analysis or use
of the data beyond that, even by parties previously considered covered by this
IGA, must be submitted to Maricopa OE at http://www.maricopa.gov/epi and
will be considered similar to all other academic institution data requests in
compliance with OE policies and procedures.
3.
If ASU receives a request for data or information related to activities covered
under
this
IGA,
then
they
should
direct
the
party
to
http://www.maricopa.gov/epi, and Maricopa OE will work with that party in
accordance with OE policies and procedures.
B.
Data must be stored in a secure location and not downloaded.
C.
Prior to write-up and submission, conference abstracts must undergo the MCDPH OE
abstract approval and submission process. Please see Attachment XX for details.
Abstract proposals must be sent to MCDPH OE at least three (3) weeks prior to
submission for review, comment, and permission to submit.
D.
Prior to presenting MCDPH data or referencing work done for or with MCDPH under this
or past IGAs to audiences external to ASU and MCPDH, notification must be made, and
all materials submitted for review to MCDPH OE at least five (5) weeks prior to
submission. Please see Attachment XX for details.
E.
Prior to writing a manuscript that includes MCDPH data or references work done under
this or past IGAs, the project must undergo the MCDPH OE manuscript approval and
submission process. After approval of the project proposal, a manuscript draft may
proceed. Once a draft is complete, notification must be made, and all materials
submitted for review to MCDPH OE at least five (5) weeks prior to submission. Please
see Attachment xx for details.
F.
For studies, investigations, or field experiences which lead to draft manuscripts, the ASU
student(s) most involved, Pl, and OE staff will be invited to contribute and have an author
position relative to the amount of work contributed to the manuscript.
2.
SECURITY OF CONFIDENTIAL INFORMATION
A.
The Contractor shall monitor the use of all Public Health Data disclosed by MCDPH under
this IGA, including but not limited to, Personal Identifying Information, and will carefully
restrict the use and disclosure of such information as provided for herein.
11
B.
Survival of Duty to Protect Confidential Information
It is understood and agreed by the Parties that the obligations set forth in this Section 6
shall survive the expiration or termination of this IGA, except as expressly provided for
herein.
C.
Minimum Safeguards for Protected Health Information
The Contractor shall carefully restrict use and access of MCDPH Personally Identifying
Information solely to Authorized Persons and shall ensure that the Contractor
implements the following minimum safeguards to prevent a Security Breach in a manner
consistent with the requirements of this IGA or applicable law. Contractor safeguards
shall, at the minimum, require that the Contractor and its Authorized Persons:
1.
Prohibit Personally Identifying Information supplied under the terms of this IGA
from being released or disclosed to anyone not working on MCDPH data
collection and analysis as an Authorized Person.
2.
Secure all printouts containing individual identifiers or confidential data in a
locked vault, file cabinet or other method reasonably necessary to protect the
confidential information.
3.
Store all Public Health Data shared pursuant to this IGA only on secured servers
or encrypted devices within MCDPH, which, at the termination of this IGA, shall
be securely deleted upon the conclusion of this IGA consistent with the
requirements of this IGA and applicable law.
4.
If requested, provide MCDPH with a description of the security measures that
are in place to maintain the confidentiality of the data being received under this
IGA.
5.
Provide MCDPH, upon request, with a current list of Authorized Persons, and
evidence that all Authorized Persons who have access to the Public Health Data
shared under this IGA have participated in any required training and signed any
documents that are necessary to keep both MCDPH and the Contractor in
compliance with HIPAA, including but not limited to, user confidentiality
affirmation statement, HIPAA training certification or other HIPAA related
compliance documents, if applicable.
6.
Provide or continue to provide MCDPH with a copy of the contractor's procedure
for the notification of MCDPH of any Security Breach, which shall include a
requirement that any user of the Public Health Data shared under this IGA shall
immediately notify a designated individual at MCDPH of any known or
reasonably suspected Security Breach.
7.
Maintain a log of all encrypted devices and identification numbers of those
devices that are authorized to transmit, receive, or store the Public Health Data
shared under this IGA, until the data are destroyed. MCDPH may request a copy
of the log at any time during the term of the IGA or until the data are destroyed.
12
8.
Make clear to all Authorized Persons and other employees with a need to know
that the Contractor is prohibited from storing Public Health Data on non-
encrypted flash drives, CDs, external drives, smart phones or other non-
networked hard drives.
9.
Provide MCDPH prompt proof of the complete destruction of the original data
and any copies or subsidiary data sets containing Personally Identifying
Information that are developed from the original data upon the conclusion of
this IGA or at such time that such destruction is required by applicable law and
in compliance with County record retention policies. Proof of destruction may
include a certificate of destruction.
D.
Security Breach
In the event of a Security Breach, pursuant to A.RS. § 44-7501, MCDPH and the
Contractor agree to collaborate with each other on the investigation, mitigation,
remediation and, if necessary, breach notification of citizens. Pursuant to A.R.S. § 41-
3507, MCDPH shall notify ADHS and the Arizona Strategic Enterprise Technology (ASET)
Statewide Information Security and Privacy Office (SISPO) immediately upon becoming
aware or receiving notice of a Security Breach.
EXHIBIT D – Case Investigation
This Scope of Work, dated _________________, 2020, is issued pursuant to, made part of, and governed by the
Master Agreement, dated July 1, 2020 (“Master Agreement”), by and between Maricopa County Department of
Public Health (“Partner”) having its principal place of business at 301 West Jefferson Street, Phoenix Az, 85003, and
The Arizona Board of Regents for and on behalf of Arizona State University (“ASU”).
1. Contact Details.
Technical Point of Contact for ASU:
Point of Contact for Partner:
Attention: Megan Jehn, Associate Professor
Jeanene Fowler, Program Operations Administrator
Arizona State University
Maricopa County Department of Public Health
School of Human Evolution & Social Change
4041 N Central Avenue, Suite 1400
P.O. Box 872402
Phoenix, AZ 85012
Tempe, Arizona 85287-2402
Phone: 602-506-4926
Phone: 480-965-4730
Email: jeanene.fowler@maricopa.gov
Email: Megan.Jehn@asu.edu
2. Period of Performance.
July 1, 2020 to June 30, 2021 based on funding availability
3. Scope of Work.
Description of Services: ASU to assist with COVID-19 Case Investigations. Assistance includes training of staff to
conduct investigation, collecting data and providing ASU faculty, staff and students to support case investigations.
Any and all students involved, ASU will have them sign a confidentiality agreement, hereto attached to this Exhibit
and take appropriate confidentiality training.
ASU will use reasonable efforts to collect complete data from each case interviewed including disease-specific
observations (DSO). ASU will be using the MCDPH supplied Qualtrics questionnaire for collection of data.
ASU will not collect any data beyond what is included on the original MCDPH form. If there is a request for ASU to
collect data beyond what is included in the original MCDPH form, then an amendment to this Exhibit will be
processed and mutually agreed upon between ASU and MCDPH.
MCDPH shall have full access to and the right to examine, copy, and make use of any and all such data.
To achieve an optimal response rate during COVID-19 case investigations, the following contact methodology will
be attempted.
A. The student will attempt one (1) documented phone call and if no response, the
case will be closed and entered as lost to follow-up in MEDSIS.
B. If for any reason the contact information is incorrect or the phone number is
non-working, the case should be submitted to ADHS after one (1) attempt and a
note of the MEDSIS ID should be sent to MCDPH in the end-of-shift interview.
If the cost exceeds the total project costs below, then an amendment to this Exhibit will be processed and mutually
agreed upon between ASU and MCDPH.
Estimated Schedule of Deliverables-(anticipated total: $464,625):
Date:
Deliverable:
July 15, 2020
HIPAA- compliant case
management system will be built
and functioning
4 supervisors and 10 case
interviewers will be trained and
actively working
July 15, 2020 – Aug 15, 2020
20 cases/day - $9,000
August 15, 2020 – Aug 30, 2020
50 cases/day - $11,250
August 30, 2020 – Sept 15, 2020
75 cases/ day – $16, 875
September 15, 2020-June 30, 2021
100 cases/day – $427,500
**Cases per day are estimates based on variables such as on-boarding and training staff, duration of interviews,
percentage of cases that are lost to follow-up, etc.**
4. Estimated Budget and Payment Schedule
5 Supervisors: $139,104
Project Manager – Megan Jehn: $37,105
Case Investigations estimated at $15/per case: $464,625 (per above schedule of deliverables)
Estimated Payment Schedule*
Date Due:
Amount Due:
Upon Execution of Agreement
5 supervisors’ salary, Project
Manager salary, indirect
$176,209
October 1, 2020 (Estimated)
Cases completed, Indirect
$65,588
January 1, 2021 (Estimated)
Cases completed, Indirect
$148,500
April 1, 2021
Cases completed, Indirect
$148,500
June 30, 2021
Cases completed, Indirect
$148,500
* Payment will be adjusted based on cases completed and documented
ASU Payment Address (if different than above address)
Office for Research & Sponsored Projects Administration
Arizona State University
PO Box 876011
Tempe, AZ 85287-6011
Questions should be directed to the person issuing the invoice or to cashmanagement@asu.edu.
EXHIBIT E – Modeling and Analysis
This Scope of Work, dated July 1, 2020, is issued pursuant to, made part of, and governed by the Master Services
Agreement, dated July ___, 2020 (“Master Agreement”), by and between Maricopa County Department of Public
Health (“Client”) having its principal place of business at 301 West Jefferson Street, Phoenix Az, 85003, and The
Arizona Board of Regents for and on behalf of Arizona State University (“ASU”).
1. Contact Details.
Technical Point of Contact for ASU:
Point of Contact for Partner:
Attention: Tim Lant, Director of Program Development
Jeanene Fowler, Program Operations Administrator
Arizona State University
Maricopa County Department of Public Health
The Biodesign Institute
4041 N Central Avenue, Suite 1400
P.O. Box 872402
Phoeniz, AZ 85012
Tempe, Arizona 85287-2402
Phone: 602-506-4926
Phone: 202-246-8881
Email: Jeanene.fowler@maricop.gov
Email: tim.lant@asu.edu
2. Scope of Work.
Description of Services: ASU to assist with COVID-19 Modeling Studies and Interpretation of Modeling Results.
Assistance includes collecting and analyzing data related to the COVID outbreak, developing computer models and
calculations of COVID dynamics, consequences, and healthcare requirements, and communicating results in writing
and in-person with MCDHP staff and subject matter experts. Any and all students involved will sign a confidentiality
agreement, hereto attached to this Exhibit, and take appropriate confidentiality training prior to accessing any
MCDPH provided information.
MCDPH shall have full access to and the right to examine, copy, and make use of any and all data-sets, models,
source code, output, and results produced under this SOW.
To ensure an optimal response, models will be developed to include a parameter review, methodology review,
presentation of results, and interpretation/discussion of results with MCDPH. Models
A. (Base award): Epidemiology projections of COVID-incidence in Maricopa County
at the county level. Estimates will include estimated number of infections,
hospitalizations, and deaths over time. Estimates will also include comparisons
to hospital and ICU capacity. Model updates will be produced monthly.
B. Option: Spatial Cluster Analysis and case mapping. We will develop a spatial risk
model based on Maricopa County case data at the zip-code or zip-code track
level that identifies hot-spots and clusters of COVID cases.
C. Option: Capacity and Resource Distribution Model. We will develop a calculator
and database for vaccines that prioritizes vaccine distribution in finite, daily
quantities across the state to prioritized populations including at-risk individuals,
critical infrastructure personnel, and front-line healthcare workers.
D. Option: An epi-curve updating calculator. We will develop based on actuarial
reserving principles an estimator of reporting lag by day for cases,
hospitalizations, ICU stays, and deaths. This calculator will update over time to
estimate final metrics based on each daily reporting number. This will allow
MCDPH to place greater certainty in ongoing data reporting.
If the cost exceeds the total project costs below, then an amendment to this Exhibit will be processed and mutually
agreed upon between ASU and MCDPH.
3. Estimated Budget and Payment Schedule
Total Personnel Costs: $ 52,078
Other Direct Costs: $1,113
Estimated Total Project Costs not to exceed $58,510.
Options B-D referenced in 2. Scope of Work may be exercised with a fully executed amendment to this Exhibit.
Neither option will exceed a cost of $58,510.
Estimated Payment Schedule
Date Due:
Amount Due:
Upon Execution of Agreement
$14,627.50
Prototype Model (30 days)
$14,627.50
First Monthly Update (60 days)
$14,627.50
Final Update (180 days)
$14,627.50
ASU Payment Address (if different than above address)
Office for Research & Sponsored Projects Administration
Arizona State University
PO Box 876011
Tempe, AZ 85287-6011
Questions should be directed to the person issuing the invoice or to cashmanagement@asu.edu.
EXHIBIT F - Serosurvey
This Scope of Work, dated July 1, 2020, is issued pursuant to, made part of, and governed by the Master
Agreement, dated July__, 2020 (“Master Agreement”), by and between Maricopa County Department of Public
Health (“Partner”) having its principal place of business at 301 West Jefferson Street, Phoenix Az, 85003, and The
Arizona Board of Regents for and on behalf of Arizona State University (“ASU”).
1. Contact Details.
Technical Point of Contact for ASU:
Point of Contact for Partner:
Attention: Megan Jehn, Associate Professor
Jeanene Fowler, Program Operations Administrator
Arizona State University
Maricopa County Department of Public Health
School of Human Evolution & Social Change
4041 N Central Avenue, Suite 1400
P.O. Box 872402
Phoenix, AZ 85012
Tempe, Arizona 85287-2402
Phone: 602-506-4926
Phone: 480-965-4730
Email: jeanene.fowler@maricopa.gov
Email: Megan.Jehn@asu.edu
2. Period of Performance.
July 1, 2020 to June 30, 2021 based on available funds
3. Scope of Work.
Description of Services: ASU to support MCDPH in conducting a serosurvey of Maricopa County, Arizona. MCDPH
will outline the basic needs, send those to the above ASU Technical Point of Contact for review, agreement and
development of a survey plan. It is estimated the serosurvey requires at least 30 nurse phlebotomists and
depending on the survey plan by the PI, may require additional resources.
The estimated known costs below currently include: Sample Collection (30 ASU Nursing student volunteers)
Interview data collection (30 ASU pre-health student volunteers)
Planning and Logistics Supervisor
If the cost exceeds the total project costs below, then an amendment to this Exhibit will be processed and mutually
agreed upon between ASU and MCDPH.
4. Estimated Budget and Payment Schedule
Total Personnel Costs: $48,196.50
Other Direct Costs: $27,500
Total Project Costs:83,266
Not to exceed $125,000
Estimated Payment Schedule
Date Due:
Amount Due:
Upon Execution of Agreement
$20,816
October 1, 2020
$20,816
January 1, 2021
$20,816
April 1, 2021
$20,816
ASU Payment Address (if different than above address)
Office for Research & Sponsored Projects Administration
Arizona State University
PO Box 876011
Tempe, AZ 85287-6011
Questions should be directed to the person issuing the invoice or to cashmanagement@asu.edu.
EXHIBIT G – COVID-19 Special Projects
This Scope of Work, dated July 1, 2020 is issued pursuant to, made part of, and governed by the Master
Agreement, dated July ___, 2020 (“Master Agreement”), by and between Maricopa County Department of Public
Health (“Partner”) having its principal place of business at 301 West Jefferson Street, Phoenix Az, 85003, and The
Arizona Board of Regents for and on behalf of Arizona State University (“ASU”).
1. Contact Details.
Technical Point of Contact for ASU:
Point of Contact for Partner:
Attention: Megan Jehn, Associate Professor
Jeanene Fowler, Program Operations Administrator
Arizona State University
Maricopa County Department of Public health
School of Human Evolution & Social Change
4041 N Central Avenue, Suite 1400
P.O. Box 872402
Phoenix, AZ 85012
Tempe, Arizona 85287-2402
Phone: 602-506-4926
Phone: 480-965-4730
Email: jeanene.fowler@maricopa.gov
Email: Megan.Jehn@asu.edu
2. Period of Performance.
July 1, 2020 to June 30, 2021 based on funding availability
3. Scope of Work.
Description of Services: ASU to assist with COVID-19 response special projects as agreed upon by ASU and Maricopa
County. For a project to be considered:
Maricopa County will present scope of work/resources needed to ASU for review.
Maricopa County and ASU will agree upon compensation for said project.
4. Compensation
Not to Exceed $250,000.
ASU Payment Address (if different than above address)
Office for Research & Sponsored Projects Administration
Arizona State University
PO Box 876011
Tempe, AZ 85287-6011
Questions should be directed to the person issuing the invoice or to cashmanagement@asu.edu.